HealthUS FDA approves AbbVie drug for Parkinson’s disease

The U.S. Food and Drug Administration has approved an AbbVie treatment for Parkinson’s disease in adults, according to the regulator’s website on Friday.

AbbVieParkinson’s diseaseFDA approval

RReuters★★★☆☆2026-09-26 03:40Original